Merrithew & Thorsten’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-289
Closed -$73K – 54
2026
Q2
$73K Buy
289
+1
+0.3% +$233 0.06% 43
2026
Q1
$70K Buy
288
+2
+0.7% +$466 0.07% 41
2025
Q4
$59K Buy
+286
New +$56.6K 0.06% 44

Other funds holding JNJ

Merrithew & Thorsten's JNJ Position: Q3 2026 in Review

Merrithew & Thorsten sold out of Johnson & Johnson (JNJ) in Q3 2026, closing a stake of 289 shares — an estimated $73K sold.

Merrithew & Thorsten first reported a position in JNJ in Q4 2025 and held it in 3 quarters. The position peaked at $73K in Q2 2026. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Merrithew & Thorsten reported no remaining Johnson & Johnson position as of Q3 2026 after selling out during the quarter.
  • Merrithew & Thorsten sold 289 Johnson & Johnson shares in Q3 2026, an estimated $73K.
  • Merrithew & Thorsten first reported a position in Johnson & Johnson in Q4 2025 and held it in 3 quarters.
  • Merrithew & Thorsten's Johnson & Johnson position peaked at $73K in Q2 2026.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Merrithew & Thorsten's 13F filing for Q3 2026, filed 6 Nov 2026.